Willscott Naugler is a Gastroenterology physician affiliated with Oregon Health & Science University. OpenAlex indexes 71 publications with 6,149 citations (h-index 26).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3181 SW Sam Jackson Park Rd
Mail Code L461
Portland, OR 972393011
Telephone
503-494-7137Registry record last updated 7 Jan 2019.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Cook IncorporatedProgram year20251 payment
- Novo Nordisk IncProgram year20252 payments
- AstraZeneca Pharmaceuticals LPProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
44.1%Osmotic Laxative15.5%Peg-3350 And Electrolytes73%Peg3350-Sod Sul-Nacl-Kcl-Asb-C27%Part D≥74 patientsBile Acid11.1%Ursodiol100%Part D≥17 patients+ 3 more classes in this area
Cancer & immunology
27.1%Calcineurin inhibitor18.8%Tacrolimus83%Cyclosporine Modified17%Part D<11 patientsPurine Antimetabolite5.3%Azathioprine100%Part D≥11 patients+ 1 more class in this area
Anti-infectives
16.6%Nucleoside and nucleotide reverse transcriptase inhibitors8.7%Vemlidy53%Tenofovir Disoproxil Fumarate48%Part D<11 patientsHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor7.8%Entecavir100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2010–2019 per NIH RePORTER. The latest:
- Role of Bile Acids in the Initiation of Liver Regeneration
Oregon Health & Science University
FY2014$148,500K08DK083507
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Safety and Feasibility of Stereotactic Body Radiation Therapy for Patients With Hepatocellular Carcinoma and Advanced Cirrhosis Awaiting Liver Transplantation: A Prospective Pilot Clinical Trial
International Journal of Radiation Oncology*Biology*Physics
2025 - Pregnancy and weaning regulate human maternal liver size and function
Proceedings of the National Academy of Sciences
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Eric Orwoll, MD
Oregon Health & Science University
Aaron Caughey, MD
Oregon Health & Science University
Tomasz Beer, MD
Oregon Health & Science University
John Nutt, MD
Oregon Health & Science University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”